American Journal of Clinical Nutrition, Vol 68, 1358S-1363S, Copyright © 1998 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats

BH Arjmandi, MJ Getlinger, NV Goyal, L Alekel, CM Hasler, S Juma, ML Drum, BW Hollis and SC Kukreja
Department of Nutritional Sciences, Oklahoma State University, Stillwater 74078-6141, USA. arjmand@okstate.edu

Soy protein, a rich source of isoflavones, fed immediately after an ovariectomy prevents bone loss in rats. Reports of the effectiveness of natural and synthetic isoflavones in preventing or treating osteoporosis led us to examine the effect of soy protein in reversing established bone loss. Seventy-two 95-d-old female Sprague-Dawley rats were assigned to 6 groups. The rats were either sham operated (SHAM; 2 groups) or ovariectomized (OVX; 4 groups) and then fed a casein-based, semipurified diet. Thirty-five days after surgery, 1 SHAM and 1 OVX group were killed to examine the occurrence of bone loss. Thereafter, the other SHAM and 1 OVX groups continued to receive the casein-based diet. Whereas the remaining 2 OVX groups received diets in which casein was replaced by soy protein with normal (OVX+SOY) or reduced (OVX+SOY-) isoflavone content for 65 days. The OVX control group had significantly lower femoral and fourth lumbar vertebral bone densities than the SHAM group. Femoral density of rats fed SOY or SOY- diets were not significantly different from SHAM or OVX controls. This suggests a slight reversal of cortical bone loss that may be partially due to higher femoral insulin-like growth factor I mRNA transcripts resulting from both the SOY and SOY- diets. The ovariectomy-induced increases in indexes of bone turnover were not ameliorated by either of the soy diets, suggesting that any positive effect of soy was achieved through enhanced bone formation rather than slowed bone resorption. Long-term consumption of soy or its isoflavones may be needed to produce small but continued increments in bone mass.

This article has been cited by other articles:

				C. D. Johnson, E. A. Lucas, S. Hooshmand, S. Campbell, M. P. Akhter, and B. H. Arjmandi Addition of Fructooligosaccharides and Dried Plum to Soy-based Diets Reverses Bone Loss in the Ovariectomized Rat Evid. Based Complement. Altern. Med., July 30, 2008; (2008) nen050v1. [Abstract] [Full Text] [PDF]

				X. Zhang, X.-O. Shu, H. Li, G. Yang, Q. Li, Y.-T. Gao, and W. Zheng Prospective Cohort Study of Soy Food Consumption and Risk of Bone Fracture Among Postmenopausal Women Arch Intern Med, September 12, 2005; 165(16): 1890 - 1895. [Abstract] [Full Text] [PDF]

				S. Kreijkamp-Kaspers, L. Kok, D. E. Grobbee, E. H. F. de Haan, A. Aleman, J. W. Lampe, and Y. T. van der Schouw Effect of Soy Protein Containing Isoflavones on Cognitive Function, Bone Mineral Density, and Plasma Lipids in Postmenopausal Women: A Randomized Controlled Trial JAMA, July 7, 2004; 292(1): 65 - 74. [Abstract] [Full Text] [PDF]

				C. Atkinson, J. E Compston, N. E Day, M. Dowsett, and S. A Bingham The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial Am. J. Clinical Nutrition, February 1, 2004; 79(2): 326 - 333. [Abstract] [Full Text] [PDF]

				K. D. Setchell and E. Lydeking-Olsen Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies Am. J. Clinical Nutrition, September 1, 2003; 78(3): 593S - 609. [Abstract] [Full Text] [PDF]

				W. Cabot Phytoestrogens J. Am. Acad. Ortho. Surg., May 1, 2003; 11(3): 153 - 156. [Full Text] [PDF]

				S. C. Blum, S. N. Heaton, B. M. Bowman, M. Hegsted, and S. C. Miller Dietary Soy Protein Maintains Some Indices of Bone Mineral Density and Bone Formation in Aged Ovariectomized Rats J. Nutr., May 1, 2003; 133(5): 1244 - 1249. [Abstract] [Full Text] [PDF]

				D. A. Khalil, E. A. Lucas, S. Juma, B. J. Smith, M. E. Payton, and B. H. Arjmandi Soy Protein Supplementation Increases Serum Insulin-Like Growth Factor-I in Young and Old Men but Does Not Affect Markers of Bone Metabolism J. Nutr., September 1, 2002; 132(9): 2605 - 2608. [Abstract] [Full Text] [PDF]

				B. H. Arjmandi The Role of Phytoestrogens in the Prevention and Treatment of Osteoporosis in Ovarian Hormone Deficiency J. Am. Coll. Nutr., October 1, 2001; 20(90005): 398S - 402. [Abstract] [Full Text]

				C. Picherit, C. Bennetau-Pelissero, B. Chanteranne, P. Lebecque, M.-J. Davicco, J.-P. Barlet, and V. Coxam Soybean Isoflavones Dose-Dependently Reduce Bone Turnover but Do Not Reverse Established Osteopenia in Adult Ovariectomized Rats J. Nutr., March 1, 2001; 131(3): 723 - 728. [Abstract] [Full Text]

				J. W Erdman Jr, R. J Stillman, and R. A Boileau Provocative relation between soy and bone maintenance Am. J. Clinical Nutrition, September 1, 2000; 72(3): 679 - 680. [Full Text] [PDF]

				D L. Alekel, A. S. Germain, C. T Peterson, K. B Hanson, J. W Stewart, and T. Toda Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women Am. J. Clinical Nutrition, September 1, 2000; 72(3): 844 - 852. [Abstract] [Full Text] [PDF]

				J. Z. Ilich and J. E. Kerstetter Nutrition in Bone Health Revisited: A Story Beyond Calcium J. Am. Coll. Nutr., June 1, 2000; 19(6): 715 - 737. [Abstract] [Full Text] [PDF]

				M. J Messina Legumes and soybeans: overview of their nutritional profiles and health effects Am. J. Clinical Nutrition, September 1, 1999; 70(3): 439S - 450. [Abstract] [Full Text] [PDF]